The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20261690: Joshua Harris; LKCM Headwater Investments II, L.P.
FTC v. Hopper (USA), Inc.
The companies that operate the Hopper travel apps have agreed to pay $35 million and will be prohibited from deceiving consumers about fees to settle the Federal Trade Commission’s allegations that they unfairly charged consumers hidden fees and misrepresented the total prices consumers would pay and the benefits of the companies’ VIP Support and Price Freeze services.
The FTC’s complaint alleges that despite its “no hidden fees” promises, Canadian company Hopper Inc. and its Massachusetts-based subsidiary Hopper (USA) Inc., unfairly charged users without their consent for “Tip” and VIP Support fees that the company claimed were optional yet were hidden and pre-selected for consumers.
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
On February 4, 2026, the Federal Trade Commission secured a landmark settlement with Express Scripts, Inc., and its affiliated entities (collectively “ESI”). The settlement requires ESI to adopt fundamental changes to its business practices that increase transparency, are expected to drive down patients’ out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years, bring millions of dollars in new revenue to community pharmacies each year, and advance the Trump Administration’s key healthcare priorities.
20261580: Bristol-Myers Squibb Company; Jiangsu Hengrui Pharmaceuticals Co., Ltd.
20261597: Travere Therapeutics, Inc.; Everest Medicines Limited
20261599: Incyte Corporation; Star Therapeutics LLC
20261619: TACHI-S CO., LTD; Marks Gatherway Inc.
20261628: Ensign Natural Resources Holdings II LLC; ConocoPhillips
20261630: Accenture plc; Whalar Group Limited
20261634: CapVest Equity Partners V SCSp; Insignia Capital Partners, L.P.
20261658: Hull Street Energy Partners III, L.P.; FirstLight Holding Inc.
Amazon.com, Inc., U.S. v.
Amazon will pay $2.25 million in civil penalties to settle FTC allegations that the online retail giant knowingly violated the 609(e) of the Fair Credit Reporting Act by refusing to provide transaction records to consumers whose personal information was used by identity thieves to commit fraud.
Philip Serpe, In the Matter of
Complaints re SpaceX
20260276: Highmark Health; Valley Medical Facilities, Inc.
FTC v Kochava, Inc.
The FTC will prohibit data broker Kochava and its subsidiary from selling, sharing or disclosing sensitive location data without consumer consent to settle allegations the companies sold location data from hundreds of millions of mobile devices that could be used to trace the movements of individuals.